Malignant melanoma in Europe: Changes in mortality rates (1970-90) in European Community countries

Cancer Causes and Control

Volumn 8, Issue 1, 1997, Pages 85-92

  Balzi, Daniela ^a   Carli, Paolo ^b   Geddes, Marco ^c  

^a Epidemiology Unit SMPO   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Satellite Unit c/o SMPO   (Italy)

Author keywords

Cancer prevention; Europe; Melanoma; Mortality; Trends

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CONTROLLED STUDY; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL;

ADULT; AGED; EUROPE; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MORTALITY; SKIN NEOPLASMS;

EID: 0031048952     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018491323442     Document Type: Article

References (19)

1. Muir CS, Nectoux J. Time trends: Malignant melanoma of skin. In: Magnus K, ed. Trend in Cancer Incidence. Causes and Practical Implications. Washington DC: Hemisphere Publishing, 1982: 365-85.
2. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents, Vol VI. Lyon, France: International Agency for Research on Cancer, 1992; IARC Sci. Pub. No. 120: 952-3.
3. Lee JAH. Melanoma. In: Sehottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. Philadelphia, PA (USA): Saunders. 1982: 984-5.
4. Armstrong BK, Kricker A. Cutaneous melanoma. Trends in cancer incidence and mortality. Cancer Surveys 1994; 19: 219-40.
5. Thorn M, Sparen P, Bergstrom R, Adami HO. Trends in mortality rates from malignant melanoma in Sweden 1953-1987 and forecasts up to 2007. Br J Cancer 1992; 66: 563-7.
6. Cristofolini M, Piscioli F, Zumiani G. A program for detection of early cutaneous malignant melanoma in the province of Trento (Italy). Am J Dermatopathol 1984; 6(Suppl 1): 283-8.
7. Williams HC, Smith S, Du Vivier AWP. Evaluation of public education campaigns in cutaneous melanoma: The King's College Hospital experience. Br J Dermatol 1990; 123: 85-92.
8. Pehamberger H, Binder M, Knollamyer, Wolff K. Immediate effects of a public education campaign on prognostic features of melanoma. J Am Acad Dermatol 1993; 29:106-8.
9. Rampen FHJ, Van Huystee BEWL, Kiemeney LALM. Practical considerations of melanoma/skin cancer screening clinics. Dermatology 1992; 184: 90-3.
10. MacKie RM, Osterlind A, Ruiter D, et al. Report on consensus meeting of the EORTC Melanoma Group on educational needs for primary and secondary prevention of melanoma in Europe. Eur J Cancer 1991; 27: 317-23.
11. MacKie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. Br Med J 1992; 304: 1012-5.
12. World Health Organization. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: WHO, 1997.
13. Doll R. Progress against cancer: an epidemiological assessment. Am J Epidemiol 1991; 134: 675-88.
14. Boyle P, Parkin DM. Statistical methods for registries. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, eds. Cancer Registration Principles and Methods. Lyon, France: International Agency for Research on Cancer, 1991; IARC Sci. Pub. No. 95: 126-58.
15. Franceschi S, Bidoli E, Prati S, Fascioli S, La Vecchia C. Mortality from skin melanoma in Italy and Friuli-Venezia Giulia Region, 1970-89. Tumori 1994; 80: 251-6.
16. Van Der Esch EP, Muir CS, Nectoux J, et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 1991; 47: 483-90.
17. Scotto J, Pitcher H, Lee JAH. Indications of future decreasing trends in skin-melanoma among whites in the United States. Int J Cancer 1991; 49: 490-7.
18. Thorn M, Adami HO, Bergstrom R, et al. Trends in survival from malignant melanoma: remarkable improvement in 23 years. JNCI 1989; 81: 611-7.
19. MacKie RM, Hunter JAA, Aitchinson TC, et al. Malignant melanoma in Scotland 1979-89. Lancet 1992; 339: 971-5.